Iain B McInnes (Iain McInnes, I B McInnes)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 37

Top Topics

Rheumatoid Arthritis

Monoclonal Antibody

Top Venues

Nature reviews. Rheumatology

Arthritis & rheumatology (Hoboken, N.J.)

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Iain B McInnes, Phillip J Mease, Yoshiya Tanaka, Laure Gossec, M Elaine Husni, Lars Erik Kristensen, Richard B Warren, Barbara Ink, Rajan Bajracharya, Jason Coarse, Alice B Gottlieb
Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52-Week Results From Two Phase 3 Studies. ACR open rheumatology (2024)
James Brock, Neil Basu, Johannes C M Schlachetzki, Larissa Valor-Méndez, Iain B McInnes, Jonathan Cavanagh
Immune mechanisms of depression in rheumatoid arthritis. Nature reviews. Rheumatology (2023)
Aurélie Najm, Carl S Goodyear, Iain B McInnes, Stefan Siebert
Phenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapy. Nature reviews. Rheumatology 19 (3) (2023)
Rongfei Wei, Xiao Han, Mengyuan Li, Yuan Ji, Lianfeng Zhang, Maria-Ioanna Christodoulou, Najwa Jameel Hameed Aga, Caiyan Zhang, Ran Gao, Jiangning Liu, Jinrong Fu, Guoping Lu, Xiaojun Xiao, Xiaoyu Liu, Ping-Chang Yang, Iain B McInnes, Ying Sun, Peisong Gao, Chuan Qin, Shau-Ku Huang, Yufeng Zhou, Damo Xu
The nuclear cytokine IL-37a controls lethal cytokine storms primarily via IL-1R8-independent transcriptional upregulation of PPARγ. Cellular & molecular immunology (2023)
Aurélie Najm, Carl S Goodyear, Iain B McInnes, Stefan Siebert
Phenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapy. Nature reviews. Rheumatology 19 (3) (2023)
Aurélie Najm, Carl S Goodyear, Iain B McInnes, Stefan Siebert
Phenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapy. Nature reviews. Rheumatology 19 (3) (2023)
Aurélie Najm, Carl S Goodyear, Iain B McInnes, Stefan Siebert
Phenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapy. Nature reviews. Rheumatology 19 (3) (2023)
Eleanor Barnes, Carl S Goodyear, Michelle Willicombe, Charlotte Gaskell, Stefan Siebert, Thushan I de Silva, Sam M Murray, Daniel Rea, John A Snowden, Miles Carroll, Sarah Pirrie, Sarah J Bowden, Susanna J Dunachie, Alex Richter, Zixiang Lim, Jack Satsangi, Gordon Cook, Ann Pope, Ana Hughes, Molly Harrison, Sean H Lim, Paul Miller, Paul Klenerman, null null, Neil Basu, Ashley Gilmour, Sophie Irwin, Georgina Meacham, Thomas Marjot, Stavros Dimitriadis, Peter Kelleher, Maria F Prendecki, Candice Clarke, Paige Mortimer, Stacey McIntyre, Rachael Selby, Naomi Meardon, Dung Nguyen, Tom Tipton, Stephanie Longet, Stephen Laidlaw, Kim Orchard, Georgina Ireland, null null, David C Thomas, Pamela Kearns, Amanda Kirkham, Iain B McInnes, null null
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease. Nature medicine (2023)
Audrey Paoletti, Bineta Ly, Catherine Cailleau, Fan Gao, Marie Péan de Ponfilly-Sotier, Juliette Pascaud, Elodie Rivière, Luxin Yang, Lilian Nwosu, Aziza Elmesmari, Franceline Reynaud, Magali Hita, David Paterson, Julien Reboud, Francois Fay, Gaetane Nocturne, Nicolas Tsapis, Iain B McInnes, Mariola Kurowska-Stolarska, Elias Fattal, Xavier Mariette
Liposomal AntagomiR-155-5p restores anti-inflammatory macrophages and improves arthritis in pre-clinical models of Rheumatoid arthritis. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Aurélie Najm, Carl S Goodyear, Iain B McInnes, Stefan Siebert
Phenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapy. Nature reviews. Rheumatology (2023)
Aurélie Najm, Carl S Goodyear, Iain B McInnes, Stefan Siebert
Phenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapy. Nature reviews. Rheumatology (2023)
Hussain Jaffery, Carmen Huesa, Sabarinadh Chilaka, John Cole, James Doonan, Moeed Akbar, Lynette Dunning, Kathleen Elizabeth Tanner, Rob J van 't Hof, Iain B McInnes, Ruaidhrí J Carmody, Carl S Goodyear
The IĸB protein BCL3 controls osteogenesis and bone health. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Aurélie Najm, Carl S Goodyear, Iain B McInnes, Stefan Siebert
Phenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapy. Nature reviews. Rheumatology 19 (3) (2023)
Aurélie Najm, Carl S Goodyear, Iain B McInnes, Stefan Siebert
Phenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapy. Nature reviews. Rheumatology 19 (3) (2023)
Yannick Degboe, Sebastiaan J Vastert, Berent J Prakken, Iain B McInnes
How does age determine the development of human immune-mediated arthritis? Nature reviews. Rheumatology 18 (9) (2022)
Christopher T Ritchlin, Phillip J Mease, Wolf-Henning Boehncke, John Tesser, Elena Schiopu, Soumya D Chakravarty, Alexa P Kollmeier, Xie L Xu, May Shawi, Yusang Jiang, Shihong Sheng, Yanli Wang, Stephen Xu, Joseph F Merola, Iain B McInnes, Atul Deodhar
Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies. RMD open 8 (1) (2022)
Effie Pournara, Matthias Kormaksson, Peter Nash, Christopher T Ritchlin, Bruce W Kirkham, Gregory Ligozio, Luminita Pricop, Alexis Ogdie, Laura C Coates, Georg Schett, Iain B McInnes
Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritis. RMD open 7 (3) (2022)
Larissa Valor-Méndez, Proton Rahman, Christopher Ritchlin, Iain B McInnes, Dirk Elewaut, Jose U Scher
Psoriatic arthritis from a mechanistic perspective. Nature reviews. Rheumatology 18 (6) (2022)
Iain B McInnes, Koji Kato, Marina Magrey, Joseph F Merola, Kishimoto Mitsumasa, César Pacheco-Tena, Derek Haaland, Liang Chen, Yuanyuan Duan, Patrick Zueger, John Liu, Ralph Lippe, Aileen L Pangan, Franck Behrens
Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study. RMD open 7 (3) (2021)
Neal L Millar, Karin G Silbernagel, Kristian Thorborg, Paul D Kirwan, Leesa M Galatz, Geoffrey D Abrams, George A C Murrell, Iain B McInnes, Scott A Rodeo
Author Correction: Tendinopathy. Nature reviews. Disease primers 7 (1) (2021)
Alexis Ogdie, Kurt de Vlam, Iain B McInnes, Phillip J Mease, Philip Baer, Tatjana Lukic, David Gruben, Kenneth Kwok, Cunshan Wang, Ming-Ann Hsu, Anna Maniccia
Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis. RMD open 6 (1) (2021)
George E Fragoulis, Jonathan Cavanagh, Alistair Tindell, Mohammad H Derakhshan, Caron Paterson, Duncan Porter, Iain B McInnes, Stefan Siebert
Depression and anxiety in an early rheumatoid arthritis inception cohort. associations with demographic, socioeconomic and disease features. RMD open 6 (3) (2021)
Kristen M Sweet, Qingxuan Song, Matthew J Loza, Iain B McInnes, Keying Ma, Karen Leander, Vani Lakshminarayanan, Carol Franks, Philip Cooper, Stefan Siebert
Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trials. RMD open 7 (2) (2021)
Laura C Coates, Laure Gossec, Elke Theander, Paul Bergmans, Marlies Neuhold, Chetan S Karyekar, May Shawi, Wim Noël, Larissa Valor-Méndez, Iain B McInnes
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS). Annals of the rheumatic diseases (2021)
Zoltán Szekanecz, Iain B McInnes, Larissa Valor-Méndez, Szilvia Szamosi, Szilvia Benkő, Gabriella Szűcs
Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases. Nature reviews. Rheumatology 17 (10) (2021)
Iain B McInnes, Proton Rahman, Alice B Gottlieb, Elizabeth C Hsia, Alexa P Kollmeier, Xie L Xu, Yusang Jiang, Shihong Sheng, May Shawi, Soumya D Chakravarty, Désirée van der Heijde, Phillip J Mease
Long-term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin-23, Through 2 Years: Results from a Phase 3, Randomized, Double-blind, Placebo-controlled Study Conducted in Biologic-naïve Patients with Active Psoriatic Arthritis. Arthritis & rheumatology (Hoboken, N.J.) (2021)
Iain B McInnes, Ellen M Gravallese
Immune-mediated inflammatory disease therapeutics: past, present and future. Nature reviews. Immunology 21 (10) (2021)
Proton Rahman, Christopher T Ritchlin, Philip S Helliwell, Wolf-Henning Boehncke, Phillip J Mease, Alice B Gottlieb, Shelly Kafka, Alexa P Kollmeier, Elizabeth C Hsia, Xie L Xu, May Shawi, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Paraneedharan Ramachandran, Yanli Zhuang, Iain B McInnes
Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic Arthritis. The Journal of rheumatology 48 (12) (2021)
Andreas Kerschbaumer, Josef S Smolen, Peter Nash, Thomas Dörner, Maxime Dougados, Roy M Fleischmann, Klaus Geissler, Iain B McInnes, Tsutomu Takeuchi, Michael Trauner, Kevin Winthrop, Maarten P T de Wit, Wolf-Henning Boehncke, Louise Falzon, Désirée Mfm van der Heijde
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research. RMD open 6 (3) (2021)
Iain B McInnes, Proton Rahman, Alice B Gottlieb, Elizabeth C Hsia, Alexa P Kollmeier, Soumya D Chakravarty, Xie L Xu, Ramanand A Subramanian, Prasheen Agarwal, Shihong Sheng, Yusang Jiang, Bei Zhou, Yanli Zhuang, Désirée van der Heijde, Phillip J Mease
Efficacy and Safety of Guselkumab, an Interleukin-23p19-Specific Monoclonal Antibody, Through One Year in Biologic-Naive Patients With Psoriatic Arthritis. Arthritis & rheumatology (Hoboken, N.J.) 73 (4) (2021)
Neal L Millar, Karin G Silbernagel, Kristian Thorborg, Paul D Kirwan, Leesa M Galatz, Geoffrey D Abrams, George A C Murrell, Iain B McInnes, Scott A Rodeo
Tendinopathy. Nature reviews. Disease primers 7 (1) (2021)
Sean Kerrigan, Iain B McInnes
Reflections on 'older' drugs: learning new lessons in rheumatology. Nature reviews. Rheumatology 16 (3) (2020)
George E Fragoulis, Katerina Chatziodionysiou, Elena Nikiphorou, Andrew Cope, Iain B McInnes
Damage Accrual in Rheumatoid Arthritis: Evaluating the Joint and Beyond. Arthritis & rheumatology (Hoboken, N.J.) 72 (12) (2020)
Flavia Sunzini, Iain B McInnes, Stefan Siebert
JAK inhibitors and infections risk: focus on herpes zoster. Therapeutic advances in musculoskeletal disease 12 (2020)
Stefano Alivernini, Lucy MacDonald, Aziza Elmesmari, Samuel Finlay, Barbara Tolusso, Maria Rita Gigante, Luca Petricca, Clara Di Mario, Laura Bui, Simone Perniola, Moustafa Attar, Marco Gessi, Anna Laura Fedele, Sabarinadh Chilaka, Domenico Somma, Stephen N Sansom, Andrew Filer, Charles McSharry, Neal L Millar, Kristina Kirschner, Alessandra Nerviani, Myles J Lewis, Costantino Pitzalis, Andrew R Clark, Gianfranco Ferraccioli, Irina A Udalova, Christopher Dominic Buckley, Elisa Gremese, Iain B McInnes, Thomas Dan Otto, Mariola Kurowska-Stolarska
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nature medicine 26 (8) (2020)
Iain B McInnes, Gianfranco Ferraccioli, Maria Antonietta D'Agostino, Manuela Le Bars, Subhashis Banerjee, Harris A Ahmad, Yedid Elbez, Phillip J Mease
Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a post hoc analysis of a phase III trial. RMD open 5 (1) (2019)
Iain B McInnes, Soumya D Chakravarty, Isabel Apaolaza, Shelly Kafka, Elizabeth C Hsia, Yin You, Arthur Kavanaugh
Efficacy of ustekinumab in biologic-naïve patients with psoriatic arthritis by prior treatment exposure and disease duration: data from PSUMMIT 1 and PSUMMIT 2. RMD open 5 (2) (2019)